Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor.

Chen Y, Perussia B, Campbell KS.

J Immunol. 2007 Sep 1;179(5):2766-73.

2.

Human peripheral CD2-/lo T cells: an extrathymic population of early differentiated, developing T cells.

Loza MJ, Luppi P, Kiefer K, Martin ES, Szczytkowski JL, Perussia B.

Int Immunol. 2005 Sep;17(9):1213-25. Epub 2005 Jul 18.

PMID:
16027135
3.

Peripheral NK cell phenotypes: multiple changing of faces of an adapting, developing cell.

Perussia B, Chen Y, Loza MJ.

Mol Immunol. 2005 Feb;42(4):385-95. Review.

PMID:
15607789
4.

Purification of peripheral blood natural killer cells.

Perussia B, Loza MJ.

Methods Mol Med. 2005;107:147-61. No abstract available.

PMID:
15492370
5.

The IL-12 signature: NK cell terminal CD56+high stage and effector functions.

Loza MJ, Perussia B.

J Immunol. 2004 Jan 1;172(1):88-96.

6.

Differential regulation of NK cell proliferation by type I and type II IFN.

Loza MJ, Perussia B.

Int Immunol. 2004 Jan;16(1):23-32.

PMID:
14688057
7.

Linear "2-0-1" lymphocyte development: hypotheses on cellular bases for immunity.

Perussia B, Loza MJ.

Trends Immunol. 2003 May;24(5):235-41. Review. No abstract available.

PMID:
12738416
9.

Multiple color immunofluorescence for cytokine detection at the single-cell level.

Loza MJ, Faust JS, Perussia B.

Mol Biotechnol. 2003 Mar;23(3):245-58.

PMID:
12665694
10.

NKT and T cells: coordinate regulation of NK-like phenotype and cytokine production.

Loza MJ, Metelitsa LS, Perussia B.

Eur J Immunol. 2002 Dec;32(12):3453-62.

11.
12.

Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.

Azzoni L, Papasavvas E, Chehimi J, Kostman JR, Mounzer K, Ondercin J, Perussia B, Montaner LJ.

J Immunol. 2002 Jun 1;168(11):5764-70.

14.

Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4.

Loza MJ, Peters SP, Zangrilli JG, Perussia B.

Eur J Immunol. 2002 Feb;32(2):413-23.

15.

Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?

Loza MJ, Perussia B.

Nat Immunol. 2001 Oct;2(10):917-24.

PMID:
11577347
16.

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.

Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC.

J Immunol. 2001 Sep 15;167(6):3114-22.

17.

B-Myb overexpression results in activation and increased Fas/Fas ligand-mediated cytotoxicity of T and NK cells.

Powzaniuk MA, Trotta R, Loza MJ, Harth A, Iozzo RV, Eisenlohr LC, Perussia B, Calabretta B.

J Immunol. 2001 Jul 1;167(1):242-9.

18.

Signaling for cytotoxicity.

Perussia B.

Nat Immunol. 2000 Nov;1(5):372-4. No abstract available.

PMID:
11062493
19.

Differential role of p38 and c-Jun N-terminal kinase 1 mitogen-activated protein kinases in NK cell cytotoxicity.

Trotta R, Fettucciari K, Azzoni L, Abebe B, Puorro KA, Eisenlohr LC, Perussia B.

J Immunol. 2000 Aug 15;165(4):1782-9.

20.

Multiple color immunofluorescence for cytokine detection at the single cell level.

Loza MJ, Faust JS, Perussia B.

Methods Mol Biol. 2000;121:193-209. Review. No abstract available.

PMID:
10818727
21.

Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cells.

Perussia B, Loza MJ.

Methods Mol Biol. 2000;121:179-92. Review. No abstract available.

PMID:
10818726
22.

The emerging role of IL-15 in NK-cell development.

Liu CC, Perussia B, Young JD.

Immunol Today. 2000 Mar;21(3):113-6. Review. No abstract available.

PMID:
10689297
23.

Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.

Trotta R, Puorro KA, Paroli M, Azzoni L, Abebe B, Eisenlohr LC, Perussia B.

J Immunol. 1998 Dec 15;161(12):6648-56.

24.

Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells.

Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B.

J Exp Med. 1998 Dec 21;188(12):2375-80.

25.

Differential transcriptional regulation of CD161 and a novel gene, 197/15a, by IL-2, IL-15, and IL-12 in NK and T cells.

Azzoni L, Zatsepina O, Abebe B, Bennett IM, Kanakaraj P, Perussia B.

J Immunol. 1998 Oct 1;161(7):3493-500.

26.

A novel surface marker (B203.13) of human haemopoietic progenitors, preferentially expressed along the B and myeloid lineages.

Zamai L, Vitale M, Bennett IM, Croce CM, Perussia B.

Br J Haematol. 1998 Sep;102(4):965-75.

PMID:
9734647
27.

Fc receptors on natural killer cells.

Perussia B.

Curr Top Microbiol Immunol. 1998;230:63-88. Review. No abstract available.

PMID:
9586351
28.

The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing.

Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B, Calabretta B.

Blood. 1998 Jan 15;91(2):406-18.

30.

Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12.

Bennett IM, Zatsepina O, Zamai L, Azzoni L, Mikheeva T, Perussia B.

J Exp Med. 1996 Nov 1;184(5):1845-56. Erratum in: J Exp Med 1997 Mar 17;185(6):1150-1.

31.

Effects of IL-12 on human natural killer cell differentiation.

Bennett IM, Perussia B.

Ann N Y Acad Sci. 1996 Oct 31;795:181-8. No abstract available.

PMID:
8958928
32.

IL-12-induced activation of NK and T cells occurs in the absence of immediate-early activation gene expression.

Azzoni L, Kanakaraj P, Zatsepina O, Perussia B.

J Immunol. 1996 Oct 15;157(8):3235-41.

PMID:
8871617
34.

The Cytokine Profile of Resting and Activated NK Cells

Perussia B.

Methods. 1996 Apr;9(2):370-8.

PMID:
8812690
35.

Purification of peripheral blood natural killer cells.

M Bennett I, Perussia B.

Methods Mol Med. 1996;2:161-71. doi: 10.1385/0-89603-335-X:161.

PMID:
21359741
37.

Phosphatidylinositol-3 kinase activity is regulated by BCR/ABL and is required for the growth of Philadelphia chromosome-positive cells.

Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G, Gewirtz AM, Perussia B, Calabretta B.

Blood. 1995 Jul 15;86(2):726-36.

38.

C-RAF-1 serine/threonine kinase is required in BCR/ABL-dependent and normal hematopoiesis.

Skorski T, Nieborowska-Skorska M, Szczylik C, Kanakaraj P, Perrotti D, Zon G, Gewirtz A, Perussia B, Calabretta B.

Cancer Res. 1995 Jun 1;55(11):2275-8.

39.

Isolation of decidual lymphocytes from chorionic villus samples: phenotypic analysis and growth in vitro.

Haynes MK, Flanagan MT, Perussia B, Jackson LG, Smith JB.

Am J Reprod Immunol. 1995 Feb;33(2):190-9.

PMID:
7544132
40.

Ligand binding to Fc gamma R induces c-myc-dependent apoptosis in IL-2-stimulated NK cells.

Azzoni L, Anegon I, Calabretta B, Perussia B.

J Immunol. 1995 Jan 15;154(2):491-9.

PMID:
7814862
41.

Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.

Skorski T, Kanakaraj P, Ku DH, Nieborowska-Skorska M, Canaani E, Zon G, Perussia B, Calabretta B.

J Exp Med. 1994 Jun 1;179(6):1855-65.

42.
43.

Phosphatidylinositol-3 kinase activation induced upon Fc gamma RIIIA-ligand interaction.

Kanakaraj P, Duckworth B, Azzoni L, Kamoun M, Cantley LC, Perussia B.

J Exp Med. 1994 Feb 1;179(2):551-8.

44.
45.

p120 GAP requirement in normal and malignant human hematopoiesis.

Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak M, Szczylik C, Zon G, Arlinghaus RB, Gewirtz A, Perussia B, Calabretta B.

J Exp Med. 1993 Dec 1;178(6):1923-33.

46.

Modulation of perforin and granzyme messenger RNA expression in human natural killer cells.

Salcedo TW, Azzoni L, Wolf SF, Perussia B.

J Immunol. 1993 Sep 1;151(5):2511-20.

PMID:
8103068
47.

Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells.

Chehimi J, Valiante NM, D'Andrea A, Rengaraju M, Rosado Z, Kobayashi M, Perussia B, Wolf SF, Starr SE, Trinchieri G.

Eur J Immunol. 1993 Aug;23(8):1826-30.

PMID:
8102101
48.

Physical and functional association of p56lck with Fc gamma RIIIA (CD16) in natural killer cells.

Salcedo TW, Kurosaki T, Kanakaraj P, Ravetch JV, Perussia B.

J Exp Med. 1993 May 1;177(5):1475-80.

49.

Soluble Fc gamma RIII (CD16) and immunoglobulin G levels in seminal plasma of men with immunological infertility.

Sedor J, Callahan HJ, Perussia B, Lattime EC, Hirsch IH.

J Androl. 1993 May-Jun;14(3):187-93.

50.

Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Zupo S, Azzoni L, Massara R, D'Amato A, Perussia B, Ferrarini M.

J Clin Immunol. 1993 May;13(3):228-36.

PMID:
7686565

Supplemental Content

Loading ...
Support Center